Brugada Syndrome With Survival of an Aborted Cardiac Arrest or With Documented Spontaneous Sustained Ventricular Tachycardia

Clinical Scenario

This protocol covers patients with Brugada syndrome who fall into one of two high-risk categories: those who have survived an aborted cardiac arrest, or those in whom spontaneous sustained ventricular tachycardia has been documented — whether on ECG or Holter monitoring.

Treatment Approach

For patients in this category, current evidence supports an implantable device-based intervention as the primary therapeutic strategy. The full protocol specifies the recommended intervention and the criteria governing its use.

Complete procedural guidance, eligibility detail, and follow-up considerations are available in the structured evidence-based protocol below.